期刊文献+

射频消融抑制小鼠乳腺癌肺转移 被引量:2

Radiofrequency ablation inhibits lung metastasis ofbreast cancer in mice
原文传递
导出
摘要 目的探讨射频消融术对小鼠三阴性乳腺癌肺转移和免疫系统的影响。方法小鼠乳腺癌4T1细胞系皮下接种于雌性Bal B/c小鼠右下肢处,肿瘤直径达到6—8mm时进行射频消融治疗,流式细胞术检测脾脏中各淋巴细胞亚群的变化,观察肺转移的情况。结果射频消融基本上可以消除原位肿瘤,原位肿瘤复发率较低;射频消融后,小鼠脾脏CD4^+T细胞、CD8^+T细胞、B细胞、自然杀伤细胞及自然杀伤T细胞数量都有所升高;射频消融治疗4T1肿瘤14d后,脱颈处死对照组和射频消融组小鼠,射频消融组和对照组4T1荷瘤小鼠的肺转移结节分别为(24±18)个和(81±35)个,差异有统计学意义(P=0.012)。射频消融抑制肺转移的机制与脾脏中CD4^+T细胞、CD8^+T细胞、B细胞和自然杀伤细胞的比例增加及髓系来源抑制细胞比例降低有关。结论射频消融增强了机体内抗肿瘤的免疫反应,抑制了小鼠4T1细胞乳腺癌的肺转移。射频消融术治疗三阴性乳腺癌和控制其远端转移可能会有良好的治疗效果。 Objective To explore the effects of radiofrequency ablation (RFA) on immune system and lung metastasis in a mouse model of triple negative breast cancer 4T1. Methods Mouse breast cancer 4T1 cells were injected into the fight hind limb of female Bal B/c mice. When the tumor size was 6-8 mm in diameter, RFA was used to treat the transplanted breast cancer in mice. We examined the splenic lymphocyte subsets by flow cytometry at different time points after RFA. Fourteen days after treatment, we sacrificed the mice of both control and treatment groups, counted the number of lung metastatic nodules, and detected the changes of splenic lymphocyte subsets by flow cytometry. Results RFA basically eliminated the orthotopic carcinoma with a low local recurrence rate. After the RFA treatment, the amount of spleic CD4^+T cells, CD8^+ T cells, B cells, NK and NKT cells was increased. Fourteen days after the RFA treatment, all mice were sacrificed, and the lung metastatic nodules were 24±18 in the control group and 81±35 in the RFA-treated group (P=0.012). The mechanism of suppression of metastatic lung cancers was related to the increase of splenic CD4^+ T cells, CD8^+T cells, B cells and NK cells, and the decrease of myeloid-derived suppressor cells. Conclusions RFA can enhance the anti-tumor immunity and effectively inhibit lung metastasis of 4T1 cell-induced breast cancer, and has a good potential effect in the treatment of triple-negative breast cancer and the control of distant metastasis.
出处 《中华肿瘤杂志》 CAS CSCD 北大核心 2015年第7期497-500,共4页 Chinese Journal of Oncology
关键词 乳腺肿瘤 消融技术 肿瘤转移 小鼠 免疫系统 Breast neoplasms Ablation techniques Neoplasm metastasis Mice Immune system
  • 相关文献

参考文献14

  • 1张智坚,吴孟超,刘崎,陈栋.不同影像方法对射频消融治疗肝癌疗效的评价[J].中华肿瘤杂志,2005,27(10):616-619. 被引量:29
  • 2王忠敏,陈克敏.影像引导下射频消融治疗的现状与进展[J].介入放射学杂志,2009,18(5):321-323. 被引量:16
  • 3Yoshinaga Y, Enomoto Y, Fujimitsu R, et al. Image and pathologicalchanges after radiofrequency ablation of invasive breast cancer: apilot study of nonsurgical therapy of early breast cancer[ J] . WorldJ Surg, 2013, 37(2) :356-363.
  • 4Noguchi M, Motoyoshi A, Earashi M,et al. Long-term outcome ofbreast cancer patients treated with radiofrequency ablation[ J]. EurJ Surg Oncol, 2012, 38( 11) : 1036-1042.
  • 5Yoshinaga Y, Enomoto Y, Fujimitsu R, et al. Image and pathologicalchanges after radiofrequency ablation of invasive breast cancer : apilot study of nonsurgical therapy of early breast cancer[ J]. WorldJ Surg, 2013,37(2) ;356-363.
  • 6Singh M,Ramos I,Asafu-Adjei D, et al. Curcumin improves thetherapeutic efficacy of Listeria (at) -Mage-b vaccine in correlationwith improved T-cell responses in blood of a triple-negative breastcancer model 4T1 [ J]. Cancer Med, 2013,2(4) :571-582.
  • 7Dent R, Trudeau M, Pritchard KI, et al. Triple-negative breastcancer : clinical features and patterns of recurrence [ J ]. ClinCancer Res, 2007,13( 15 Pt 1) :4429-4434.
  • 8关印,徐兵河.三阴性乳腺癌的临床病理特征及预后分析[J].中华肿瘤杂志,2008,30(3):196-199. 被引量:63
  • 9Saiwai H, Kumamaru H, Ohkawa Y, et al. Ly6C+ Ly6G- Myeloid-derived suppressor cells play a critical role in the resolution of acuteinflammation and the subsequent tissue repair process after spinalcord injury[ J] . J Neurochem, 2013,125( 1) ;74-88.
  • 10Zerfcini A, Pilli M, Penna A, et al. Radiofrequency thermal ablation ofhepatocellular carcinoma liver nodules can activate and enhancetumor-specific T-cell responses[ J]. Cancer Res, 2006,66(2):1139-1146.

二级参考文献37

  • 1吴乔,马宽生,别平.脾脏毁损体积对射频消融治疗脾脏功能亢进症疗效的影响[J].消化外科,2006,5(3):191-193. 被引量:11
  • 2吴宇旋,窦永充,张彦舫,沈新颖,郑雪芬,孙国平,徐坚民.经皮射频消融治疗膈下肝癌[J].介入放射学杂志,2006,15(12):728-731. 被引量:16
  • 3赵卫红,徐兵河,张频,李青,赵龙妹,孙燕.乳腺癌合并脉管瘤栓的临床病理特点及预后因素分析[J].中华肿瘤杂志,2007,29(2):137-140. 被引量:14
  • 4Carey LA, Perou CM, Livasy CA, et al. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA, 2006, 295:2492-2502.
  • 5Carlson RW, Moench SJ, Hammond ME, et al. HER2 testing in breast cancer: NCCN Task Force report and recoannendations. J Natl Compr Canc Netw, 2006, 4 Suppl 3 :S1-22.
  • 6Cleator S, Heller W, Coombes RC. Triple-negative breast cancer: therapeutic options. Lancet Oncol, 2007, 8:235-244.
  • 7Rakha EA, El-Sayed ME, Green AR, et al. Prognostic markers in triple-negative breast cancer. Cancer, 2007, 109:25-32.
  • 8Perez EA, Roche PC, Jenkins RB, et al. HER2 testing in patients with breast cancer: poor correlation between weak positivity by immunohistochemistry and gene amplification by fluorescence in situ hybridization. Mayo Clin Proc, 2002, 77:148-154.
  • 9Kandel MJ, Stadler Z, Masciari S, et al. Prevalence of BRCA1 mutations in triple negative breast cancer (BC). Proc Am Soc Clin Oncol, 2006, 24 :abstr 508.
  • 10Herr A, Gluz O, Ting E, et al. Biological characteristics in triple negative high risk breast cancer and their clinical implications. Proc Am Soc Clin Oncol, 2006, 24 : abstr 20032.

共引文献104

同被引文献23

  • 1陈理明,李晓洁,蔡应木,王少彬,陈俊辉.肝癌肺癌患者射频消融治疗后细胞免疫功能变化[J].实用医学杂志,2006,22(21):2467-2468. 被引量:11
  • 2何维.医学免疫学[M].2版.北京:人民卫生出版社,2010:414.
  • 3Dupuy DE,Zagoria RJ,Akerley W,et al.Percutaneous ra- diofrequency ablation of malignancies in the lung[J].Am J Roentgenol, 2000, 174( 1 ) : 57-59.
  • 4Zhu JF, Paul WE.CD4 T cells : fates, functions, and faults [J].Blood, 2008,12(5) : 1557-1569.
  • 5Ivanova EA, Orekhov AN.T helper lymphocyte subsets and plasticity in autoimmunity and cancer:an overview [J]. Biomed Res Int, 2015,2015 : 327470.
  • 6Gasper DJ,Tejera MM, Suresh M.CD4 T-cell memory generation and maintenance[J].Crit Rev Immunol,2014,34(2) : 121-146.
  • 7Boost KA,Sadik CD,Bachmann M,et al.IFN-gamma im- pairs release of IL-8 by IL-lbeta-stimulated A549 lung carcinoma cells[J].BMC Cancer, 2008, (8) : 265.
  • 8Li J,Wang Z,Mao K,et al.Clinical significance of serum T helper 1/T helper 2 cytokine shift in patients with non- small cell lung cancer[J].Oncol Lett,2014,8 (4): 1682- 1686.
  • 9Nguyen AH, Berim IG,Agrawal DK.Cellular and molec- ular immunology of lung cancer:therapeutic implications [J].Expert Rev Clin Immunol, 2014, 10(12) : 1711-1730.
  • 10Pan B, Shen J, Cao J,et al.Interleukin- 17 promotes angio- genesis by stimulating VEGF production of cancer cells via the STAT3/GIV signaling pathway in non-small-cell lung cancer[J].Sci Rep, 2015, (5) : 16053.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部